Age: 86.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Ischaemic stroke, Rhabdomyolysis
Clinical narrative: LIKELY TRAUMATIC RHABDOMYOLYSIS; ISCHAEMIC STROKE; This spontaneous report received from a health care professional via the Regulatory Authority Vaccine Adverse Event Reporting System ( ID: 1282506), in addition to information received via literature, Ad26.COV2.S COVID-19 Vaccination. Vaccines 2021, 27-AUG-2021, 1-7. This report concerned an 86 year old male patient of unspecified race, and ethnicity. The objective of this study was to research is needed to better understand the underlying pathomechanism and to investigate whether subcutaneous injection of vaccines may be able to prevent rhabdomyolysis. The patient's height, and weight were not reported. The patient's concurrent conditions included essential hypertension, and depression. The patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, 1 total, administered on APR-2021 for prophylactic vaccination. The batch number was not reported. The company was unable to perform follow up to request batch/lot numbers. Concomitant medications included atenolol, and rosuvastatin calcium. On an unspecified date in APR-2021, the patient experienced ischaemic stroke and likely traumatic rhabdomyolysis. On 28-APR-2021, the patient visited local emergency department. The patient was laying on the floor for a few days prior to hospitalization. On an unspecified date the patient was hospitalized. On an unspecified date the patient was discharged from the hospital and was recovering at a skilled nursing facility. The patient had no acute kidney failure and was hospitalized for 2 days. The time to symptom onset was reported as 4 weeks. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from likely traumatic rhabdomyolysis, and had not recovered from ischaemic stroke. The authors emphasized on physicians should be aware of the possibility of vaccine-induced rhabdomyolysis as a potentially serious side-effect in patients particularly in times of mass vaccinations. Patients may be advised to monitor the color of their urine for the early detection of rhabdomyolysis. This report was serious (Hospitalization Caused / Prolonged, and Life Threatening). This case, from Same Literature article is linked to 20210923039, 20210543394, 20210721677, 20210924327, 20210914711, 20210705289, 20210705289, 20210757800, 20210762171, 20210905291, 20210923028, 20210923042, 20210922810, 20210639871, 20210528129 and 20210922624.  Additional information was received on 07-SEP-2021. The following information was updated and incorporated into the case narrative: Literature source added, reporters added, event rhabdomyolysis was updated to likely traumatic rhabdomyolysis, outcome of likely traumatic rhabdomyolysis was updated from not recovered/not resolved to recovered/resolved and the case level outcome was updated from not recovered/not resolved to recovered/resolved.; Sender's Comments: V1: Follow up information in this version updated: Literature source, reporters ,event rhabdomyolysis was updated to likely traumatic rhabdomyolysis, outcome of likely traumatic rhabdomyolysis and the case level outcome was updated.  20210528518-Covid-19 vaccine ad26.cov2.s-Likely traumatic rhabdomyolysis. Follow-up received regarding Clinical Details. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).  20210528518-Covid 19 Vaccine-This case concerns with 86 yr old male, Ischaemic stroke. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).